cognos-therapeutics-medical-device-technology-neuropathic-disease-mitagation-clinical-trail-herceptin-featured-image
Recent Posts
- Cognos Therapeutics, Inc. To Be Publicly Listed On Nasdaq
- Labroot’s Report Focuses on the Need To Develop Better Methods To Deliver Therapeutics to the Brain
- Cognos Co-Founder and CIO Josh Shachar Discusses The Evolution of the Cognos Vision
- Cognos Engages Maxim Group for Investment Banking and Financial Advisory Services
- Cognos Announces Addition of New Clean Room To Expand Its Development Capabilites.
Recent Comments